Skip to content
Review

Artificial Intelligence in Druggable Protein Identification: Data-driven Multidimensional Representations and the Evolution of Predictive Models.

Aug 2026 · Current Drug Targets · 0 citations
Medicine

TL;DR

This review systematically summarizes the latest research progress in druggable protein prediction algorithms, providing a comprehensive analysis across three dimensions: data resources, feature engineering, and predictive models.

Abstract

Druggable proteins are proteins that can be specifically bound and modulated by drug molecules, with such modulation expected to produce therapeutic effects. The identification and validation of druggable proteins are central steps in modern drug discovery. With the rapid advancements in biological big data and artificial intelligence, computational methods based on bioinformatics have become essential for large-scale screening of druggable proteins. This review systematically summarizes the latest research progress in this field, providing a comprehensive analysis across three dimensions: data resources, feature engineering, and predictive models. The main contributions are 4-fold: First, we systematically describe three major types of databases: pharmacological annotation databases, quantitative affinity databases, and multi-source integrated databases, and dataset construction strategies as well as strategies for handling imbalanced samples are explored. Second, multi-level feature representations across four dimensions are categorized into sequencederived features, physicochemical properties, evolutionary information, and structural information, and the corresponding methods and tools are summarized. Third, we provide a detailed review of the evolution and application paradigms of predictive models, from classical machine learning and ensemble learning to deep learning architectures and protein large language models. Fourth, based on a systematic evaluation of representative studies, current limitations in areas such as few-shot learning and model interpretability are highlighted, and offer a forward-looking perspective on future research directions. This review aims to serve as a comprehensive reference for druggable protein prediction algorithms and to provide a solid theoretical and technical roadmap for computationally driven discovery of novel drug targets.

View source

Similar papers

Review Open access Sep 2026

APPLICATIONS OF DATA ANALYSIS AND ARTIFICIAL INTELLIGENCE AGENTS IN NOVEL DRUG DISCOVERY: A CRITICAL LITERATURE REVIEW

This evidence-based literature review critically examines the evolution and application of computational technologies across the pharmaceutical pipeline, ranging from early expert systems like DENDRAL, computer-aided drug design (CADD), and quantitative structure-activity relationship (QSAR) modeling to AlphaFold 3 bio...

Leonardo Mairene Muniz · 0 citations
Review Sep 2026

Significant Advances in Research on Drug-Drug Interactions in the Past Five Years

This review systematically analyzes key challenges in DDI prediction: balancing model performance with interpretability, integrating heterogeneous features, ensuring sample set reliability, and optimizing algorithmic architectures, and outlines promising directions for future innovation.

Yun Zuo, Jia-Yi Ji, Yuwen Li et al. · 0 citations
Review Open access Aug 2026

Artificial Intelligence-Driven Natural Product Drug Discovery: From Computational Genome Mining to Clinical Translation.

An operational, end-to-end workflow that explicitly connects computational predictions to medicinal chemistry decision points is provided, addressing a critical gap between computational prediction and clinical translation.

Antonio Lavecchia · 0 citations
Review 2026

How Can Structure-Based Computational Methods Support Antibiotic Drug Discovery in Addressing Antimicrobial Resistance?

It is concluded that computational protein structure prediction plays a critical role in accelerating antibiotic drug discovery and offers substantial potential for addressing antimicrobial resistance through more efficient and data-driven therapeutic development strategies.

Hanshal Inagala · 0 citations
Review Sep 2026

Revolution of Computer-assisted Drug Design: The Transformative Role of Artificial Intelligence.

Artificial intelligence (AI) is transforming computer-aided drug design (CADD) by enabling more rapid, efficient, and data-driven approaches to drug discovery. This narrative review examines recent applications of AI, machine learning (ML), deep learning (DL), reinforcement learning (RL), natural language processing (N...

Uma Rawat, Anita Singh · 0 citations
Review Open access Aug 2026

AI in Drug Development: Applications and Challenges

It is essential to view AI technologies as an instrumental but supplementary part of decision-making in pharmaceutical research and development rather than a fully independent alternative to traditional hit- and lead-discovery strategies.

Saikat Biswas, Somenath Bhattacharya, Soumallya Chakraborty · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.